Received Nov 19, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| IPV | POLIO VIRUS, INACT. (NO BRAND NAME) | UNKNOWN MANUFACTURER | UNK | — | OT |
administration of polio subcutaneous in the right upper abdominal quadrant with no reported adverse event; Initial information received on 12-Nov-2025 regarding an unsolicited valid non-serious case received from a pharmacist. This case involves an unknown age/gender patient who was administered POLIOMYELITIS VACCINE (INACTIVATED) subcutaneously in the right upper abdominal quadrant with no reported adverse event. The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided. On an unknown date, the patient received a dose of suspect POLIOMYELITIS VACCINE (INACTIVATED) produced by unknown manufacturer (dose, strength, lot and expiry: unknown) via subcutaneous route in the right upper abdominal quadrant with no reported adverse event (product administered at inappropriate site) (latency same day) for prophylactic vaccination (immunization). Information on batch number and expiry date corresponding to the one at time of event occurrence was requested. Action taken was not applicable. This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.